VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 56 filers reported holding VERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,133,246 | +24.8% | 2,562,600 | +46.1% | 0.41% | +23.4% |
| Q2 2023 | $28,146,725 | +106.9% | 1,753,690 | +0.1% | 0.33% | +80.5% |
| Q1 2023 | $13,601,092 | +370.0% | 1,752,718 | +1072.0% | 0.18% | +374.4% |
| Q4 2022 | $2,893,851 | -19.8% | 149,553 | -11.7% | 0.04% | -22.0% |
| Q3 2022 | $3,607,000 | – | 169,277 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |